Matrix,Inc.

12/27/2025

01/04/2024

SomaCode is solving the problem of cell therapy delivery by identifying unique molecular “zip codes” for disease and engineering cells to home to those zip codes, making cell therapies safer and more effective.

01/21/2020

Stem Cells Technology for regenerative medicine

04/19/2019

For the first time in recorded history, scientists have created a working, vascularized engineered heart using human cells by printing it in 3D. The advancement, which could change medicine forever, was unveiled in a study published in Advanced Science on Monday. "This is the first time anyone anywhere has successfully engineered and printed an entire heart replete with cells, blood vessels, ventricles and chambers," said Tel Aviv University professor Tal Dvir in a statement.⁣⁣⁣
⁣⁣⁣The study was inspired by the prevalence of heart disease in both Israel and the U.S. According to data compiled by the CDC, heart disease is the leading cause of death for men and women, accounting for the deaths of more than 600,000 people every year.

02/19/2019

Matrix, Inc. is a privately-held company, specializing in innovative materials-based technology for applications in Nanotechnology and Biotechnology. Matrix, Inc. has a manufacturing facility, a quality control laboratory, a research and development laboratory and a warehouse space. The company is an international registered manufacturer with a quality system that is in compliance with the Quality System Regulations and certified to European ISO, working on the cutting edge of 3D tissue engineering using stem cell-based technologies.
Our company transforms lives through innovative medical solutions that improve the health of patients around the world.